CA2984899C — Synthesis of 1 h-pyrrolo[2,3-b]pyridin derivatives that modulate kinases
Assigned to Daiichi Sankyo Co Ltd · Expires 2021-06-15 · 5y expired
What this patent protects
The present disclosure provides processes for the preparation of a compound of formula (I): or a salt thereof, active on the receptor protein kinases c-Kit and/or c-Fms and/or Flt3. The disclosure also provides compounds and processes for the preparation of the compounds that are…
USPTO Abstract
The present disclosure provides processes for the preparation of a compound of formula (I): or a salt thereof, active on the receptor protein kinases c-Kit and/or c-Fms and/or Flt3. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula (I).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.